U.S. Health Secretary RFK Jr.’s decision to cancel funding for mRNA vaccine development dismantles a public health tool and ...

The vaccine used in this trial, known as AHEAD-MERIT (BNT113-01), will help the immune system recognise and kill cancer cells ...

U.S. Health Secretary Robert F. Kennedy Jr. incorrectly argued mRNA vaccines are ineffective to justify the Department of ...

Health Secretary Robert F. Kennedy Jr. announced plans on Tuesday to cancel 22 mRNA vaccine development contracts totaling nearly $500 million. The move follows a “comprehensive review of mRNA-related ...

German drugmaker CureVac and GSK reached an agreement with BioNTech and Pfizer on Thursday to resolve a years-long patent ...

The U.S. Department of Health and Human Services announced a significant shift in vaccine funding, spearheaded by Health ...

The U.S. Department of Health and Human Services announced a significant shift in vaccine funding, spearheaded by Health ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...

CureVac said on Thursday that the company and GSK have entered an agreement to a resolve patent dispute with Pfizer and ...

Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Cuts to mRNA research stir fears Health ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...